Brief: SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis
18/10/2024 13:38
Oct 18 (Reuters) - SeaStar Medical Holding Corp ICU.O :
* SEASTAR MEDICAL ANNOUNCES THAT ENROLLMENT IN ITS ADULT
ACUTE
KIDNEY INJURY PIVOTAL TRIAL HAS EXCEEDED THE HALFWAY POINT
TOWARD AN INTERIM ANALYSIS
Source text for Eikon: ID:nGNX24JcwW
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview